课题基金 / 基金详情

ADENOSINE A2 RECEPTORS AND PSYCHOSTIMULANT INTERACTIONS

ADENOSINE A2 RECEPTORS AND PSYCHOSTIMULANT INTERACTIONS
腺苷 A2 受体和精神兴奋剂的相互作用
批准号:
2770084
负责人:
MICHAEL A SCHWARZSCHILD
金额:
$29.85万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-08-01 至 2000-08-31

项目摘要

项目成果

MICHAEL A SCHWARZSCHILD的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Applicant's Abstract) Long-term administration of psychostimulant drugs produces enduring changes in behavior. It is likely that the long-term changes in brain function associated with prolonged drug exposure are important to addictive behavior. The molecular mechanisms underlying the persistent alteration in brain function associated with prolonged psychostimulant exposure are poorly understood. The behavioral effects of the psychostimulant amphetamine are dependent on activation of dopamine receptors within the striatum and limbic forebrain. Repeated administration of psychostimulants to rodents produces alterations in nuclear proteins which may underlie long-lasting changes in behavior. The A2a subtype of adenosine receptor is expressed in and regulates responsiveness of D2-expressing striatal and limbic forebrain neurons, and modulates the behavioral and nuclear responses of acute amphetamine. The A1 adenosine receptor also modulates AMPH-induced behavior, but the anatomical basis of this A1 effect is not understood. We hypothesize that striatal and limbic forebrain A2a and A1 adenosine receptors are sites where the acute effects of AMPH and enduring changes in brain function following chronic AMPH can be regulated. The expression of striatal and limbic forebrain A2a and A1 receptors will be characterized and the roles that these adenosinergic receptors play in modulating the behavioral and nuclear effects of acute and chronic AMPH administration will be investigated. These experiments will begin to identify nuclear mechanisms underlying this form of drug-induced neural plasticity which are vulnerable to modulation by forebrain adenosinergic receptors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Planning for Prevention of Parkinson's Disease: a trial design forum
  • 批准号:
    10827547
  • 项目类别:
  • 资助金额:
    $6.0万
  • 财政年份:
    2023
  • 负责人:
    MICHAEL A SCHWARZSCHILD
  • 依托单位:
2019 Parkinson Study Group Symposium and Training
  • 批准号:
    9763271
  • 项目类别:
  • 资助金额:
    $2.5万
  • 财政年份:
    2019
  • 负责人:
    MICHAEL A SCHWARZSCHILD
  • 依托单位:
Urate-LRRK2 interactions in Parkinson's disease
  • 批准号:
    10427325
  • 项目类别:
  • 资助金额:
    $38.84万
  • 财政年份:
    2019
  • 负责人:
    MICHAEL A SCHWARZSCHILD
  • 依托单位:
Urate-LRRK2 interactions in Parkinson's disease
  • 批准号:
    9978147
  • 项目类别:
  • 资助金额:
    $40.38万
  • 财政年份:
    2019
  • 负责人:
    MICHAEL A SCHWARZSCHILD
  • 依托单位:
海外基金